133
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Evaluation of the Anti-Leishmanial Effect of Recombinant Clostridium α-Toxin

ORCID Icon, , , , , , , & show all
Pages 2355-2364 | Published online: 15 Jul 2020

References

  • Sharma U, Singh S Immunobiology of leishmaniasis. 2009.
  • Sacks D, Kamhawi S. Molecular aspects of parasite-vector and vector-host interactions in leishmaniasis. Ann Rev Microbiol. 2001;55(1):453–483. doi:10.1146/annurev.micro.55.1.45311544364
  • Singh N, Kumar M, Singh RK. Leishmaniasis: current status of available drugs and new potential drug targets. Asian Pac J Trop Med. 2012;5(6):485–497. doi:10.1016/S1995-7645(12)60084-422575984
  • Zheng Z, Tweten RK, Mensa-Wilmot K. Intracellular glycosylphosphatidylinositols accumulate on endosomes: toxicity of alpha-toxin to Leishmania major. Eukaryot Cell. 2005;4(3):556–566. doi:10.1128/EC.4.3.556-566.200515755918
  • Tellez G, Pumford NR, Morgan MJ, Wolfenden AD, Hargis BM. Evidence for Clostridium septicum as a primary cause of cellulitis in commercial turkeys. J Veterinary Diagn Invest. 2009;21(3):374–377. doi:10.1177/104063870902100313
  • Liechti M, Schöb O, Kacl G, Caduff B. Clostridium septicum aortitis in a patient with colon carcinoma. Eur J Clin Microbiol Infect Dis. 2003;22(10):632–634. doi:10.1007/s10096-003-1009-014513404
  • Koransky JR, Stargel MD, Dowell V Jr. Clostridium septicum bacteremia its clinical significance. Am J Med. 1979;66(1):63–66. doi:10.1016/0002-9343(79)90483-2420252
  • Ballard J, Bryant A, Stevens D, Tweten R. Purification and characterization of the lethal toxin (alpha-toxin) of Clostridium septicum. Infect Immun. 1992;60(3):784–790. doi:10.1128/IAI.60.3.784-790.19921541552
  • Hickey MJ, Kwan RY, Awad MM, et al. Molecular and cellular basis of microvascular perfusion deficits induced by Clostridium perfringens and Clostridium septicum. PLoS Pathog. 2008;4(4):e1000045. doi:10.1371/journal.ppat.100004518404211
  • Melton-Witt JA, Bentsen LM, Tweten RK. Identification of functional domains of Clostridium septicum alpha toxin. Biochemistry. 2006;45(48):14347–14354. doi:10.1021/bi061334p17128973
  • Gordon VM, Benz R, Fujii K, Leppla SH, Tweten RK. Clostridium septicum alpha-toxin is proteolytically activated by furin. Infect Immun. 1997;65(10):4130–4134. doi:10.1128/IAI.65.10.4130-4134.19979317018
  • Melton JA, Parker MW, Rossjohn J, Buckley JT, Tweten RK. The identification and structure of the membrane-spanning domain of the Clostridium septicum alpha toxin. J Biol Chem. 2004;279(14):14315–14322. doi:10.1074/jbc.M31375820014715670
  • Wichroski MJ, Melton JA, Donahue CG, Tweten RK, Ward GE. Clostridium septicum alpha-toxin is active against the parasitic protozoan Toxoplasma gondii and targets members of the SAG family of glycosylphosphatidylinositol-anchored surface proteins. Infect Immun. 2002;70(8):4353–4361. doi:10.1128/IAI.70.8.4353-4361.200212117945
  • Sellman BR, Kagan BL, Tweten RK. Generation of a membrane‐bound, oligomerized pre‐pore complex is necessary for pore formation by Clostridium septicum alpha toxin. Mol Microbiol. 1997;23(3):551–558. doi:10.1046/j.1365-2958.1997.d01-1876.x9044288
  • Knapp O, Maier E, Mkaddem SB, et al. Clostridium septicum alpha-toxin forms pores and induces rapid cell necrosis. Toxicon. 2010;55(1):61–72. doi:10.1016/j.toxicon.2009.06.03719632260
  • Swartz JR. Advances in Escherichia coli production of therapeutic proteins. Curr Opin Biotechnol. 2001;12(2):195–201. doi:10.1016/S0958-1669(00)00199-311287237
  • Li Y, Li X, Wang G. Cloning, expression, isotope labeling, and purification of human antimicrobial peptide LL-37 in Escherichia coli for NMR studies. Protein Expr Purif. 2006;47(2):498–505. doi:10.1016/j.pep.2005.10.02216325420
  • Das S, Chatterjee N, Bose D, et al. Lipid isolated from a Leishmania donovani strain reduces Escherichia coli induced sepsis in mice through inhibition of inflammatory responses. Mediators Inflamm. 2014;2014.
  • Uk L. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227(259):680–685. doi:10.1038/227680a05432063
  • Sanbrook J, Fritsch E, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1989.
  • Morais-Teixeira E, Damasceno QS, Galuppo MK, Romanha AJ, Rabello A. The in vitro leishmanicidal activity of hexadecylphosphocholine (miltefosine) against four medically relevant Leishmania species of Brazil. Mem Inst Oswaldo Cruz. 2011;106(4):475–478. doi:10.1590/S0074-0276201100040001521739037
  • Taheri T, Rafati S. Leishmaniasis: recombinant DNA vaccination and different approaches for vaccine development. Clin Investig (Lond). 2013;3(11):1023–1044. doi:10.4155/cli.13.99
  • Yadava A, Ockenhouse CF. Effect of codon optimization on expression levels of a functionally folded malaria vaccine candidate in prokaryotic and eukaryotic expression systems. Infect Immun. 2003;71(9):4961–4969. doi:10.1128/IAI.71.9.4961-4969.200312933838
  • Xu C, Xu C, Zhao Z. Expression of alpha-toxin gene of Clostridium perfringens type A and its primary immunological protective function. Wei Sheng Wu Xue Bao= Acta Microbiologica Sinica. 2006;46(4):624–628.17037067
  • Inoue M, Kikuchi M, Komoriya T, Kohno H. Cloning of Clostridium perfringens alpha-toxin gene and extracellular expression in Escherichia coli. Rinsho Biseibutsu Jinsoku Shindan Kenkyukai Shi= JARMAM: Journal of the Association for Rapid Method and Automation in Microbiology. 2007;18(2):127–135.18154441
  • Zhang Y, Bian Y, Zhao B. The study on the cloning and expression of alpha toxin gene of Clostridium septicum and the immunity of the toxoid. Sheng Wu Gong Cheng Xue Bao= Chinese Journal of Biotechnology. 2007;23(1):67–72.17366890
  • Tweten RK. Clostridium perfringens beta toxin and Clostridium septicum alpha toxin: their mechanisms and possible role in pathogenesis. Vet Microbiol. 2001;82(1):1–9. doi:10.1016/S0378-1135(01)00372-811423190
  • Podešvová L, Leštinová T, Horáková E, Lukeš J, Volf P, Yurchenko V. Suicidal Leishmania. Pathogens. 2020;9(2):79. doi:10.3390/pathogens9020079
  • Mirzaei F, Khanahmad H, Namdar F, Izadi S, Hejazi SH. A novel strategy for enhance potentiation of meglumine anti-moniate against leishmania major in vitro. Iran J Parasitol. 2019;14(4):542–551.32099557